Overview

Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2017-12-26
Target enrollment:
Participant gender:
Summary
This Phase IV clinical study is to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Rheumatoid Arthritis Patients
Phase:
Phase 4
Details
Lead Sponsor:
Dong-A ST Co., Ltd.
Treatments:
Celecoxib